CXCR3 and rheumatoid arthritis: Although this study found a significance difference in the levels of receptor expression of CD4+CD183+ between RA cases and healthy controls, the decreased levels of CD4+CD183+ may explain the reason for most RA patients presenting with low to moderate disease activity in this study, and that the weak correlation may be due to the small sample size used in this study.